{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-278985","form_type":"8-K","ticker":"IOBTQ","cik":"0001865494","company_name":"IO Biotech, Inc.","filed_at":"2024-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.165407+00:00","generated_at":"2026-05-29T03:07:37.876865+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"IO Biotech adopts amended and restated bylaws effective December 13, 2024","bullets":["Amended bylaws revise procedural mechanics for stockholder director nominations and other business proposals.","New provisions address compliance with Rule 14a-19 under the Exchange Act regarding universal proxy.","Updates to stockholder meeting procedures and director eligibility requirements are included.","Changes conform to recent amendments to the Delaware General Corporation Law.","Other ministerial and clarifying amendments were made effective immediately."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-278985","json":"https://secwatch.observer/filing/0001193125-24-278985.json","markdown":"https://secwatch.observer/filing/0001193125-24-278985.md","text":"https://secwatch.observer/filing/0001193125-24-278985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865494/000119312524278985/0001193125-24-278985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865494/000119312524278985/d896239d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T03:07:37.876865+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b8236578dd1259d4b5da07a1c49c80053846f10f","claim":"IO Biotech, Inc.: Adopted amended and restated bylaws with revisions to stockholder nomination mechanics, Rule 14a-19 compliance, meeting procedures, DGCL conformity, and ministerial changes (effective 2024-12-13).","evidence_excerpt":"On December 13, 2024, the board of directors (the “Board”) of IO Biotech, Inc. (the “Company”) adopted amended and restated bylaws of the Company (the bylaws, as so amended and restated, the “Amended and Restated Bylaws”), effective immediately.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1865494/000119312524278985/0001193125-24-278985-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2024-12-13"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}